Titers of antiphospholipid antibodies (aCL IgG and IgM and β2GPI-IgG and IgM) in cancer patients VS controls.

Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome.

Charis Pericleous
Isabel Ferreira
Orietta Borghi
Francesca Pregnolato
Thomas McDonnell
Acely Garza-Garcia
Paul Driscoll
Silvia Pierangeli
David Isenberg
Yiannis Ioannou
Ian Giles
Pier Luigi Meroni
Anisur Rahman

INTRODUCTION:Currently available clinical assays to detect antiphospholipid antibodies (aPL) test fo...

OD values for the IgG and IgM anti-CCP2 antibodies compared to the IgG and IgM anti-arginine2 antibody controls.

Lianne J. N. Kraal (5204798)
Marieke L. Nijland (5204792)
Kristine L. Germar (5204795)
Dominique L. P. Baeten (168230)
Ineke J. M. ten Berge (583651)
Cynthia M. Fehres (5204801)

May 2018

<p>Patients previously tested positive for IgG (n = 2) or IgM anti-CCP2 (n = 10) antibodies were add...

[Immunity and cancer: the role of PSA IgM Immune complexes for prostate cancer]

Zani D.
Costa S.
Beneduce L.
Fassina G.
Simeone C.
Cosciani Cunico S.

January 2010

Immunoediting is a new concept in cancer surveillance. Immunity is involved in detecting cellular wa...

Criteria and Non-Criteria Antiphospholipid Antibodies and Cancer in Patients with Involuntary Weight Loss

Simona Caraiola
Laura Voicu
Anda Baicus
Cristian Baicus

October 2023

Cancer patients have higher prevalences of antiphospholipid antibodies (aPLs), occasionally associat...

Antiphospholipid antibodies and acute-phase response in non-metastatic colorectal cancer patients.

BATTISTELLI, SANDRA
VITTORIA, AURELIO
ROVIELLO, FRANCO
STEFANONI M
PETRIOLI R
GENOVESE A
DELL'AVANZATO R
DONATI G

January 2008

AIM: To investigate the plasma levels and prevalence of the most common antiphospholipid antibodies,...

Serum cardiolipin antibodies in cancer patients with thromboembolic events

Serdengecti, S
Arun, B
Erzin, Y
Demir, G
Demirelli, F
Mandel, NM
Buyukunal, E
Berkarda, B
Ozduroglu, M

January 1999

This study was undertaken to investigate a possible association of anticardiolipin antibodies (ACLAs...

Antibodies to Domain 4/5 (Dm4/5) of \u3b22-Glycoprotein 1 (\u3b22GP1) in different antiphospholipid (aPL) antibody profiles

Pengo, Vittorio
Ruffatti, Amelia
Tonello, Marta
Hoxha, Ariela
Bison, Elisa
Denas, Gentian
PADAYATTIL JOSE, Seena
Zoppellaro, Giacomo
Bracco, Alessia
Banzato, Alessandra

January 2015

Determination of the three recommended tests for the diagnosis of antiphospholipid syndrome [Lupus A...

Antibodies to Domain I of β2-Glycoprotein I are in Close Relation to Patients Risk Categories in Antiphospholipid Syndrome (APS)

A. BANZATO
POZZI, NICOLA
FRASSON, ROBERTA
DE FILIPPIS, VINCENZO
RUFFATTI, AMELIA
E. BISON
S. J. PADAYATTIL
G. DENAS
PENGO, VITTORIO

January 2011

INTRODUCTION: Antiphospholipid Syndrome (APS) is characterized by the presence of circulating antiph...

Influence of anticardiolipin and anti-β2 glycoprotein I antibody cutoff values on antiphospholipid syndrome classification

Vanoverschelde, Laura
Kelchtermans, Hilde
Musial, Jacek
de Laat, Bas
Devreese, Katrien M J

July 2019

Background: Anticardiolipin (aCL) and anti-β2 glycoprotein I (aβ2GPI) immunoglobulin (Ig) G/IgM anti...

Antiphospholipid Antibodies in Patients with Myasthenia Gravis

Kinoshita, Ikuo
Motomura, Masakatsu
Nagasato, Kunihiko
Ichinose, Katsuhiro
Ohishi, Kiyosumi
Takeo, Gou
Satoh, Akira
Nakamura, Tatsufumi
Yoshimura, Toshiro
Tsujihata, Mitsuhiro
Nagataki, Shigenobu

October 1994

We measured antiphospholipid antibodies in sera from 94 patients with myasthenia gravis (MG). We fou...

Semiquantitative interpretation of anticardiolipin and antiβ2glycoprotein I antibodies measured with various analytical platforms: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies

Vandevelde, A.
Chayoua, W.
de Laat, B.
Gris, J.C.
Moore, G.W.
Musial, J.
Zuily, S.
Wahl, D.
Devreese, K.M.J.

February 2022

Background Anti beta 2glycoprotein I (a beta 2GPI) and anticardiolipin (aCL) IgG/IgM show difference...

Semiquantitative interpretation of anticardiolipin and antiβ2glycoprotein I antibodies measured with various analytical platforms : communication from the ISTH SSC subcommittee on lupus anticoagulant/antiphospholipid antibodies

Vandevelde, Arne
Chayoua, Walid
de Laat, Bas
Gris, Jean‐Christophe
Moore, Gary W.
Musiał, Jacek
Zuily, Stéphane
Wahl, Denis
Devreese, Katrien

January 2022

Background Anti beta 2glycoprotein I (a beta 2GPI) and anticardiolipin (aCL) IgG/IgM show difference...

Is Increase of Homocysteine, Anti-Cardiolipin, Anti-Phospholipid

alireza abdollahi

November 2015

<div><p>Patients with malignancy are at higher risk of thrombotic complications due to the hypercoag...

Study for validate aCL antibodies (IgG and IgM) as screening to identify patients positive for aPL consensus (aCL and aB2GP1 IgG/IgM).

Carlos Tortosa (4261507)
Oscar Cabrera-Marante (4261495)
Manuel Serrano (239323)
José A. Martínez-Flores (4261510)
Dolores Pérez (210503)
David Lora (332752)
Luis Morillas (4261504)
Estela Paz-Artal (4261513)
José M. Morales (4261501)
Daniel Pleguezuelo (4261498)
Antonio Serrano (494436)

July 2017

<p>Study for validate aCL antibodies (IgG and IgM) as screening to identify patients positive for aP...

IgA anticardiolipin and IgA anti-\u3b22 glycoprotein I antibody positivity determined by fluorescence enzyme immunoassay in primary antiphospholipid syndrome.

Mattia, Elena
Ruffatti, Amelia
Tonello, M
Meneghel, L
Robecchi, B
Pittoni, M
Gallo, N
Salvan, E
Teghil, V
Punzi, Leonardo
Plebani, Mario

January 2014

BACKGROUND: Primary antiphospholipid syndrome (PAPS) is an autoimmune disease characterized by throm...

Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome.

Charis Pericleous
Isabel Ferreira
Orietta Borghi
Francesca Pregnolato
Thomas McDonnell
Acely Garza-Garcia
Paul Driscoll
Silvia Pierangeli
David Isenberg
Yiannis Ioannou
Ian Giles
Pier Luigi Meroni
Anisur Rahman

INTRODUCTION:Currently available clinical assays to detect antiphospholipid antibodies (aPL) test fo...

OD values for the IgG and IgM anti-CCP2 antibodies compared to the IgG and IgM anti-arginine2 antibody controls.

Lianne J. N. Kraal (5204798)
Marieke L. Nijland (5204792)
Kristine L. Germar (5204795)
Dominique L. P. Baeten (168230)
Ineke J. M. ten Berge (583651)
Cynthia M. Fehres (5204801)

May 2018

<p>Patients previously tested positive for IgG (n = 2) or IgM anti-CCP2 (n = 10) antibodies were add...

[Immunity and cancer: the role of PSA IgM Immune complexes for prostate cancer]

Zani D.
Costa S.
Beneduce L.
Fassina G.
Simeone C.
Cosciani Cunico S.

January 2010

Immunoediting is a new concept in cancer surveillance. Immunity is involved in detecting cellular wa...

Criteria and Non-Criteria Antiphospholipid Antibodies and Cancer in Patients with Involuntary Weight Loss

Simona Caraiola
Laura Voicu
Anda Baicus
Cristian Baicus

October 2023

Cancer patients have higher prevalences of antiphospholipid antibodies (aPLs), occasionally associat...

Antiphospholipid antibodies and acute-phase response in non-metastatic colorectal cancer patients.

BATTISTELLI, SANDRA
VITTORIA, AURELIO
ROVIELLO, FRANCO
STEFANONI M
PETRIOLI R
GENOVESE A
DELL'AVANZATO R
DONATI G

January 2008

AIM: To investigate the plasma levels and prevalence of the most common antiphospholipid antibodies,...

Serum cardiolipin antibodies in cancer patients with thromboembolic events

Serdengecti, S
Arun, B
Erzin, Y
Demir, G
Demirelli, F
Mandel, NM
Buyukunal, E
Berkarda, B
Ozduroglu, M

January 1999

This study was undertaken to investigate a possible association of anticardiolipin antibodies (ACLAs...

Antibodies to Domain 4/5 (Dm4/5) of \u3b22-Glycoprotein 1 (\u3b22GP1) in different antiphospholipid (aPL) antibody profiles

Pengo, Vittorio
Ruffatti, Amelia
Tonello, Marta
Hoxha, Ariela
Bison, Elisa
Denas, Gentian
PADAYATTIL JOSE, Seena
Zoppellaro, Giacomo
Bracco, Alessia
Banzato, Alessandra

January 2015

Determination of the three recommended tests for the diagnosis of antiphospholipid syndrome [Lupus A...

Antibodies to Domain I of β2-Glycoprotein I are in Close Relation to Patients Risk Categories in Antiphospholipid Syndrome (APS)

A. BANZATO
POZZI, NICOLA
FRASSON, ROBERTA
DE FILIPPIS, VINCENZO
RUFFATTI, AMELIA
E. BISON
S. J. PADAYATTIL
G. DENAS
PENGO, VITTORIO

January 2011

INTRODUCTION: Antiphospholipid Syndrome (APS) is characterized by the presence of circulating antiph...

Influence of anticardiolipin and anti-β2 glycoprotein I antibody cutoff values on antiphospholipid syndrome classification

Vanoverschelde, Laura
Kelchtermans, Hilde
Musial, Jacek
de Laat, Bas
Devreese, Katrien M J

July 2019

Background: Anticardiolipin (aCL) and anti-β2 glycoprotein I (aβ2GPI) immunoglobulin (Ig) G/IgM anti...

Antiphospholipid Antibodies in Patients with Myasthenia Gravis

Kinoshita, Ikuo
Motomura, Masakatsu
Nagasato, Kunihiko
Ichinose, Katsuhiro
Ohishi, Kiyosumi
Takeo, Gou
Satoh, Akira
Nakamura, Tatsufumi
Yoshimura, Toshiro
Tsujihata, Mitsuhiro
Nagataki, Shigenobu

October 1994

We measured antiphospholipid antibodies in sera from 94 patients with myasthenia gravis (MG). We fou...

Semiquantitative interpretation of anticardiolipin and antiβ2glycoprotein I antibodies measured with various analytical platforms: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies

Vandevelde, A.
Chayoua, W.
de Laat, B.
Gris, J.C.
Moore, G.W.
Musial, J.
Zuily, S.
Wahl, D.
Devreese, K.M.J.

February 2022

Background Anti beta 2glycoprotein I (a beta 2GPI) and anticardiolipin (aCL) IgG/IgM show difference...

Semiquantitative interpretation of anticardiolipin and antiβ2glycoprotein I antibodies measured with various analytical platforms : communication from the ISTH SSC subcommittee on lupus anticoagulant/antiphospholipid antibodies

Vandevelde, Arne
Chayoua, Walid
de Laat, Bas
Gris, Jean‐Christophe
Moore, Gary W.
Musiał, Jacek
Zuily, Stéphane
Wahl, Denis
Devreese, Katrien

January 2022

Background Anti beta 2glycoprotein I (a beta 2GPI) and anticardiolipin (aCL) IgG/IgM show difference...

Is Increase of Homocysteine, Anti-Cardiolipin, Anti-Phospholipid

alireza abdollahi

November 2015

<div><p>Patients with malignancy are at higher risk of thrombotic complications due to the hypercoag...

Study for validate aCL antibodies (IgG and IgM) as screening to identify patients positive for aPL consensus (aCL and aB2GP1 IgG/IgM).

Carlos Tortosa (4261507)
Oscar Cabrera-Marante (4261495)
Manuel Serrano (239323)
José A. Martínez-Flores (4261510)
Dolores Pérez (210503)
David Lora (332752)
Luis Morillas (4261504)
Estela Paz-Artal (4261513)
José M. Morales (4261501)
Daniel Pleguezuelo (4261498)
Antonio Serrano (494436)

July 2017

<p>Study for validate aCL antibodies (IgG and IgM) as screening to identify patients positive for aP...

IgA anticardiolipin and IgA anti-\u3b22 glycoprotein I antibody positivity determined by fluorescence enzyme immunoassay in primary antiphospholipid syndrome.

Mattia, Elena
Ruffatti, Amelia
Tonello, M
Meneghel, L
Robecchi, B
Pittoni, M
Gallo, N
Salvan, E
Teghil, V
Punzi, Leonardo
Plebani, Mario

January 2014

BACKGROUND: Primary antiphospholipid syndrome (PAPS) is an autoimmune disease characterized by throm...

Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome.

Charis Pericleous
Isabel Ferreira
Orietta Borghi
Francesca Pregnolato
Thomas McDonnell
Acely Garza-Garcia
Paul Driscoll
Silvia Pierangeli
David Isenberg
Yiannis Ioannou
Ian Giles
Pier Luigi Meroni
Anisur Rahman

INTRODUCTION:Currently available clinical assays to detect antiphospholipid antibodies (aPL) test fo...

OD values for the IgG and IgM anti-CCP2 antibodies compared to the IgG and IgM anti-arginine2 antibody controls.

Lianne J. N. Kraal (5204798)
Marieke L. Nijland (5204792)
Kristine L. Germar (5204795)
Dominique L. P. Baeten (168230)
Ineke J. M. ten Berge (583651)
Cynthia M. Fehres (5204801)

May 2018

<p>Patients previously tested positive for IgG (n = 2) or IgM anti-CCP2 (n = 10) antibodies were add...

[Immunity and cancer: the role of PSA IgM Immune complexes for prostate cancer]

Zani D.
Costa S.
Beneduce L.
Fassina G.
Simeone C.
Cosciani Cunico S.

January 2010

Immunoediting is a new concept in cancer surveillance. Immunity is involved in detecting cellular wa...

Titers of antiphospholipid antibodies (aCL IgG and IgM and β2GPI-IgG and IgM) in cancer patients VS controls.

Abstract

Extracted data

Titers of antiphospholipid antibodies (aCL IgG and IgM and β2GPI-IgG and IgM) in cancer patients VS controls.

Abstract

Extracted data

Related items

Related items